Patents by Inventor Andrew Gelman

Andrew Gelman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170368104
    Abstract: The present disclosure relates to methods of inducing tolerance to lung allograft transplantation. These methods comprise increasing suppressor CD8+ T cells and/or suppressing deleterious CD8+ and CD4+ T cells.
    Type: Application
    Filed: September 1, 2017
    Publication date: December 28, 2017
    Inventors: Alexander Sasha Krupnick, Daniel Kreisel, Andrew Gelman
  • Publication number: 20150023919
    Abstract: The present disclosure relates to methods of inducing tolerance to lung allograft transplantation. These methods comprise increasing nitric oxide, increasing suppressor CD8+ T cells and/or suppressing deleterious CD8+ and CD4+ T cells.
    Type: Application
    Filed: July 17, 2014
    Publication date: January 22, 2015
    Inventors: Alexander Sasha Krupnick, Daniel Kreisel, Andrew Gelman
  • Patent number: 5585646
    Abstract: Improved bio-electronic devices in which a layer of a polyhydroxy oligomer is provided between the surface of a semiconductor material and an electronically active biochemical molecule which is designed to be bound to the semiconductor surface to provide an electronic device. The layer of polyhydroxy oligomer functions as a biochemical stabilization layer to prevent denaturization of the electronically active biochemical molecule.
    Type: Grant
    Filed: May 23, 1995
    Date of Patent: December 17, 1996
    Assignee: The Regents of the University of California
    Inventors: Nir Kossovsky, Andrew Gelman, H. James Hnatyszyn, Samir Rajguru
  • Patent number: 5506420
    Abstract: Improved bio-electronic devices in which a layer of a polyhydroxy oligomer is provided between the surface of a semiconductor material and an electronically active biochemical molecule which is designed to be bound to the semiconductor surface to provide an electronic device. The layer of polyhydroxy oligomer functions as a biochemical stabilization layer to prevent denaturization of the electronically active biochemical molecule.
    Type: Grant
    Filed: September 14, 1994
    Date of Patent: April 9, 1996
    Assignee: The Regents of the University of California
    Inventors: Nir Kossovsky, Andrew Gelman, H. James Hnatyszyn, Samir Rajguru
  • Patent number: 5462751
    Abstract: A biologically active composition made up of biodegradable core particles which are coated with a layer that is designed to allow attachment of biologically active agents without denaturing them. The composition may further include an exterior targeting membrane which provides selective targeting to specific receptors.
    Type: Grant
    Filed: November 1, 1993
    Date of Patent: October 31, 1995
    Assignee: The Regeants of the University of California
    Inventors: Nir Kossovsky, H. James Hnatyszyn, Andrew Gelman
  • Patent number: 5460831
    Abstract: A biologically active composition for use in gene therapy and other transfection procedures. The composition is composed of nanocrystalline core particles which are coated with a layer that is designed to allow attachment of transfection agents (DNA/RNA segments or antisense fragments) without denaturing them. The composition may further include an exterior targeting membrane which provides selective targeting of the transfection agents to specific cell receptors.
    Type: Grant
    Filed: November 4, 1993
    Date of Patent: October 24, 1995
    Assignee: The Regents of the University of California
    Inventors: Nir Kossovsky, H. James Hnatyszyn, Andrew Gelman
  • Patent number: 5460830
    Abstract: A biologically active composition made up of core particles or surfaces which are coated with a layer which is designed to allow attachment of biochemically reactive pairs (BRP's) without denaturing the BRP to the microparticles. BRP's which may be attached include ligand-receptor pairs, enzyme-substrate pairs, drug-receptor pairs, catalyst-reactant pairs, toxin-ligand pairs, absorbant-absorbate pairs and adsorbant-adsorbate pairs.
    Type: Grant
    Filed: November 1, 1993
    Date of Patent: October 24, 1995
    Assignee: The Regents of the University of California
    Inventors: Nir Kossovsky, Edward Sponsler, Andrew Gelman, Samir Rajguru